Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study

Patients with cirrhosis are vulnerable to hepatic decompensation events and death following COVID-19 infection. Therefore, primary vaccination with COVID-19 vaccines is fundamental to reducing the risk of COVID-19 related deaths in patients with cirrhosis. However, limited data are available about t...

Descripción completa

Detalles Bibliográficos
Autores principales: Drácz, Bálint, Müller, Veronika, Takács, István, Hagymási, Krisztina, Dinya, Elek, Miheller, Pál, Szijártó, Attila, Werling, Klára
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861308/
https://www.ncbi.nlm.nih.gov/pubmed/36679899
http://dx.doi.org/10.3390/vaccines11010050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861308/
https://www.ncbi.nlm.nih.gov/pubmed/36679899
http://dx.doi.org/10.3390/vaccines11010050

Ejemplares similares